Select Medical Holdings Corporation (NYSE:SEM) Receives Consensus Rating of “Hold” from Analysts

Shares of Select Medical Holdings Corporation (NYSE:SEM) have earned a consensus recommendation of “Hold” from the seven brokerages that are covering the company, Marketbeat Ratings reports. Six research analysts have rated the stock with a hold recommendation and one has given a buy recommendation to the company. The average 1 year target price among analysts that have updated their coverage on the stock in the last year is $15.50.

Several research analysts have recently commented on the company. Benchmark lowered Select Medical from a “buy” rating to a “hold” rating in a report on Wednesday, March 4th. Weiss Ratings upgraded shares of Select Medical from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, June 4th. Wall Street Zen downgraded shares of Select Medical from a “buy” rating to a “hold” rating in a research note on Monday, March 9th. Mizuho reissued a “neutral” rating and issued a $16.50 price target (down from $17.00) on shares of Select Medical in a research note on Tuesday, May 12th. Finally, Royal Bank Of Canada restated a “sector perform” rating and set a $16.50 price target (down from $19.00) on shares of Select Medical in a report on Tuesday, March 3rd.

Select Medical Trading Up 0.0%

Shares of Select Medical stock opened at $16.67 on Monday. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.15 and a quick ratio of 1.15. The stock’s 50 day simple moving average is $16.47 and its 200-day simple moving average is $15.84. The stock has a market cap of $2.07 billion, a P/E ratio of 15.72, a P/E/G ratio of 0.96 and a beta of 1.01. Select Medical has a 1-year low of $11.65 and a 1-year high of $16.99.

Select Medical (NYSE:SEM) last announced its quarterly earnings data on Thursday, April 30th. The health services provider reported $0.36 EPS for the quarter, missing analysts’ consensus estimates of $0.43 by ($0.07). The company had revenue of $1.42 billion for the quarter, compared to analysts’ expectations of $1.41 billion. Select Medical had a return on equity of 6.62% and a net margin of 2.42%.The business’s quarterly revenue was up 5.0% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.44 EPS. Select Medical has set its FY 2026 guidance at 1.220-1.320 EPS. Analysts predict that Select Medical will post 1.26 EPS for the current fiscal year.

Select Medical announced that its board has initiated a stock repurchase program on Thursday, February 19th that allows the company to buyback $1.00 billion in shares. This buyback authorization allows the health services provider to buy up to 49.5% of its shares through open market purchases. Shares buyback programs are usually an indication that the company’s leadership believes its shares are undervalued.

Select Medical Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, May 28th. Investors of record on Thursday, May 14th were given a $0.0625 dividend. This represents a $0.25 annualized dividend and a yield of 1.5%. The ex-dividend date was Thursday, May 14th. Select Medical’s dividend payout ratio is presently 23.58%.

Hedge Funds Weigh In On Select Medical

Hedge funds have recently modified their holdings of the business. Dana Investment Advisors Inc. increased its position in shares of Select Medical by 52.9% during the 3rd quarter. Dana Investment Advisors Inc. now owns 524,621 shares of the health services provider’s stock worth $6,736,000 after purchasing an additional 181,436 shares during the last quarter. Public Sector Pension Investment Board lifted its position in Select Medical by 21.3% in the third quarter. Public Sector Pension Investment Board now owns 430,472 shares of the health services provider’s stock valued at $5,527,000 after buying an additional 75,530 shares during the last quarter. Western Standard LLC purchased a new position in Select Medical during the third quarter worth about $13,551,000. CSM Advisors LLC increased its position in shares of Select Medical by 32.0% during the third quarter. CSM Advisors LLC now owns 298,961 shares of the health services provider’s stock valued at $3,840,000 after acquiring an additional 72,546 shares during the last quarter. Finally, JPMorgan Chase & Co. raised its stake in shares of Select Medical by 24.7% in the 3rd quarter. JPMorgan Chase & Co. now owns 554,203 shares of the health services provider’s stock valued at $7,116,000 after acquiring an additional 109,788 shares during the period. 89.48% of the stock is currently owned by hedge funds and other institutional investors.

Select Medical Company Profile

Select Medical is a leading provider of specialized healthcare services in the United States, operating through two primary business segments: Hospital Division and Outpatient Rehabilitation Division. The Hospital Division offers long-term acute care (LTAC) hospitals and inpatient rehabilitation facilities (IRFs) that serve patients recovering from complex illnesses, trauma or surgery. The Outpatient Rehabilitation Division delivers physical, occupational and speech therapy services through a network of clinic locations and home-based care programs.

Headquartered in Mechanicsburg, Pennsylvania, Select Medical was founded in 1996 and has grown through strategic partnerships, joint ventures and acquisitions.